UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leukemia cell to endothelial cell communication via exosomal miRNAs

Oncogene, 2013-05, Vol.32 (22), p.2747-2755

2013

Volltextzugriff (PDF)

Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin : in vitro and in vivo studies in acute leukemia

Oncogene, 2006-09, Vol.25 (42), p.5719-5725

2006

Volltextzugriff (PDF)

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

Blood cancer journal (New York), 2012-01, Vol.2 (1), p.e53-e53

2012

Volltextzugriff (PDF)

Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy

Leukemia, 2003-03, Vol.17 (3), p.560-567

2003

Volltextzugriff (PDF)

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

Leukemia, 2005-12, Vol.19 (12), p.2359-2360

2005

Volltextzugriff (PDF)

Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK T-cell lymphoma and chronic active EBV infection

British journal of cancer, 2006-02, Vol.94 (4), p.599-608

2006

Volltextzugriff (PDF)

Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors

Oncogene, 2007-06, Vol.26 (28), p.4179-4188

2007

Volltextzugriff (PDF)

Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells

British journal of cancer, 2005-05, Vol.92 (10), p.1942-1947

2005

Volltextzugriff (PDF)

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia

International journal of oncology, 2004-06, Vol.24 (6), p.1481

2004

Volltextzugriff (PDF)

Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals

Human genetics, 1998-04, Vol.102 (4), p.397-402

1998

Volltextzugriff (PDF)

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

Leukemia, 1999-03, Vol.13 (3), p.393-399

1999

Volltextzugriff (PDF)

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

Blood cancer journal (New York), 2012-01, Vol.2 (1), p.e53

2012

Volltextzugriff (PDF)

Reply to Kremer M et al., the JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

Leukemia, 2006-07, Vol.20 (7), p.1297-1298

2006

Volltextzugriff (PDF)

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways

Oncogene, 2003-08, Vol.22 (34), p.5338-5347

2003

Volltextzugriff (PDF)

Clinical implications of telomerase activity levels in acute leukemia

Clinical cancer research, 1997-04, Vol.3 (4), p.619-625

1997

Volltextzugriff (PDF)

Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2V617F mutation

Leukemia, 2007-07, Vol.21 (7), p.1578-1580

2007

Volltextzugriff (PDF)

Thrombosis can occur at any phase of essential thrombocythemia with JAK2V617F mutation : a single institutional study in Japan

Leukemia, 2007-07, Vol.21 (7), p.1570-1571

2007

Volltextzugriff (PDF)

Telomere Stability Is Frequently Impaired in High-Risk Groups of Patients with Myelodysplastic Syndromes

Clinical cancer research, 1999-05, Vol.5 (5), p.1155-1160

1999

Volltextzugriff (PDF)

JAK2V617F mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders

Leukemia, 2007-05, Vol.21 (5), p.1097-1099

2007

Volltextzugriff (PDF)

Telomere length shortening in patients with dementia with Lewy bodies

European journal of neurology, 2012-06, Vol.19 (6), p.905-910

2012

Volltextzugriff (PDF)

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

Leukemia, 1997-02, Vol.11 (2), p.190-194

1997

Volltextzugriff (PDF)

Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay

Cancer research (Chicago, Ill.), 1997-06, Vol.57 (11), p.2100-2103

1997

Volltextzugriff (PDF)

Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (13), p.3557-3560

1994

Volltextzugriff (PDF)

Telomerase Activity in Lung Cancer Cells Obtained From Bronchial Washings

JNCI : Journal of the National Cancer Institute, 1998-05, Vol.90 (9), p.684-690

1998

Volltextzugriff (PDF)

Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells

British journal of cancer, 2007-10, Vol.97 (8), p.1099-1105

2007

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(254)
Japanisch
(48)

Erscheinungsjahr

n.n

Thema

Humans
(201)
Life Sciences & Biomedicine
(169)
Science & Technology
(169)
Oncology
(126)
Biological And Medical Sciences
(125)
Medical Sciences
(115)
Male
(114)
Hematologic And Hematopoietic Diseases
(92)
Middle Aged
(90)
Female
(89)
Adult
(88)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(86)
Aged
(74)
Hematology
(66)
Karyotyping
(51)
Genetics & Heredity
(43)
Myelodysplastic Syndromes - Genetics
(35)
Chromosome Aberrations
(31)
Adolescent
(28)
Leukemia, Myeloid, Acute - Genetics
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Leukemia cell to endothelial cell communication via exosomal miRNAs

Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin : in vitro and in vivo studies in acute leukemia

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK T-cell lymphoma and chronic active EBV infection

Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors

Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells

A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia

Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders

Reply to Kremer M et al., the JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways

Clinical implications of telomerase activity levels in acute leukemia

Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2V617F mutation

Thrombosis can occur at any phase of essential thrombocythemia with JAK2V617F mutation : a single institutional study in Japan

Telomere Stability Is Frequently Impaired in High-Risk Groups of Patients with Myelodysplastic Syndromes

JAK2V617F mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders

Telomere length shortening in patients with dementia with Lewy bodies

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay

Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes

Telomerase Activity in Lung Cancer Cells Obtained From Bronchial Washings

Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells

Suchergebnisse filtern